Use of the MNCD Classification to Monitor Clinical Stage and Response to Levodopa-Entacapone-Carbidopa Intestinal Gel Infusion in Advanced Parkinson's Disease.
Santos-García D, López-Manzanares L, Muro I, Lorenzo-Barreto P, Casas Peña E, García-Ramos R, Fernández Valle T, Morata-Martínez C, Baviera-Muñoz R, Martínez-Torres I, Álvarez-Sauco M, Alonso-Modino D, Legarda I, Valero-García MF, Suárez-Muñoz JA, Martínez-Castrillo JC, Perona AB, Salom JM, Cubo E, Valero-Merino C, López-Ariztegui N, Alonso PS, Novo Ponte S, Gamo Gónzález E, Martín García R, Espinosa R, Carmona M, Feliz CE, García Ruíz P, Muñoz Ruíz T, Fernández Rodríguez B, Alvarez-Santullano MM.
Santos-García D, et al. Among authors: alonso ps.
Brain Sci. 2024 Dec 12;14(12):1244. doi: 10.3390/brainsci14121244.
Brain Sci. 2024.
PMID: 39766443
Free PMC article.